Cargando…
Histone deacetylase inhibitiors enhance sensitivity of murine sarcoma tumors to IL-13-PE immunotoxin-based cancer therapy by upregulating IL-13Rα2 expression in vitro and in vivo
Autores principales: | Fujisawa, Toshio, Nakashima, Hideyuki, Joshi, Bharat H, Puri, Raj K |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3991088/ http://dx.doi.org/10.1186/2051-1426-1-S1-P73 |
Ejemplares similares
-
Histone modification enhances the effectiveness of IL-13 receptor targeted immunotoxin in murine models of human pancreatic cancer
por: Fujisawa, Toshio, et al.
Publicado: (2011) -
IL-13Rα2 Is a Biomarker of Diagnosis and Therapeutic Response in Human Pancreatic Cancer
por: Fujisawa, Toshio, et al.
Publicado: (2021) -
IL-13Rα2 Status Predicts GB-13 (IL13.E13K-PE4E) Efficacy in High-Grade Glioma
por: Rechberger, Julian S., et al.
Publicado: (2022) -
Interleukin-13 receptor α2 DNA prime boost vaccine induces tumor immunity in murine tumor models
por: Nakashima, Hideyuki, et al.
Publicado: (2010) -
Upregulation of p75NTR by Histone Deacetylase Inhibitors Sensitizes Human Neuroblastoma Cells to Targeted Immunotoxin-Induced Apoptosis
por: Dedoni, Simona, et al.
Publicado: (2022)